RFA for Gastric Intestinal Metaplasia-Should We Do It Just Because We Can?
- PMID: 39915958
- DOI: 10.1111/jgh.16902
RFA for Gastric Intestinal Metaplasia-Should We Do It Just Because We Can?
References
-
- J. A. Trieu, M. Bilal, H. Saraireh, and A. Y. Wang, “Update on the Diagnosis and Management of Gastric Intestinal Metaplasia in the USA,” Digestive Diseases and Sciences 64, no. 5 (2019): 1079–1088.
-
- Y. Li, F. Jiang, C. Y. Wu, and W. K. Leung, “Prevalence and Temporal Trend of Gastric Preneoplastic Lesions in Asia: A Systematic Review With Meta‐Analysis,” United European Gastroenterology Journal 12, no. 1 (2024): 139–151.
-
- M. Kawamura, N. Uedo, K. Yao, et al., “Endoscopic and Histological Risk Stratification for Gastric Cancer Using Gastric Intestinal Metaplasia,” Journal of Gastroenterology and Hepatology 39, no. 9 (2024): 1910–1916.
-
- D. Hara, T. Okamura, Y. Iwaya, T. Nagaya, H. Ota, and T. Umemura, “Histopathologically Defined Intestinal Metaplasia in Lesser Curvature of Corpus Prior to Helicobacter pylori Eradication Is a Risk Factor for Gastric Cancer Development,” Helicobacter 27, no. 6 (2022): e12934.
-
- F. Zhu, X. Zhang, P. Li, and Y. Zhu, “Effect of Helicobacter pylori Eradication on Gastric Precancerous Lesions: A Systematic Review and Meta‐Analysis,” Helicobacter 28, no. 6 (2023): e13013.
Publication types
LinkOut - more resources
Full Text Sources